ANNEX II, Commission Regulation (EU) No 618/2012 of 10 July 2012 amending, for the purposes of its…

In forcesince 10 Jul 2012

Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes

Hazard Class and Category Code(s) | Hazard Statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s)

‘015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. 2 | H351 |

GSH08

Wng

H351 | | |

015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 |

Carc. 1B

Repr. 2

STOT RE 1

H350

H361f

H372 (lungs)

GHS08

Dgr

H350

H361f

H372 (lungs)

STOT RE 1;

H372: C ≥0,1 %

Carc 1B;

H350: C ≥0,01 %

STOT RE 2;

H373: 0,01 % ≤ C < 0,1 %

015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. 1B | H360F |

GHS08

Dgr

H360F | | |

015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 |

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (causing atrophy of the testes) |

GHS08

Wng

H361f (causing atrophy of the testes) | | |

602-109-00-4 | Hexabromocyclododecane [1] | 247-148-4 [1] | 25637-99-4[1] |

Repr. 2

Lact.

H361

H362

GHS08

Wng

H361

H362

1,2,5,6,9,10-hexabromocyclododecane [2] | 221-695-9[2] | 3194-55-6[2]

606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] |

Repr. 2

Acute Tox. 2

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H300

H330

H372 (nervous system)

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d

H300

H330

H372 (nervous system)

H410

STOT RE 1;

H372: C ≥ 5 %

STOT RE 2;

H373: 0,5 % ≤C<5 %

M = 10000

avermectin B1a (purity ≥80 %); [2] | 265-610-3 [2] | 65195-55-3 [2]

606-144-00-6 |

acequinocyl (ISO);

3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate

–

| 57960-19-7 |

Skin Sens. 1

STOT SE 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H370 (lung)

(inhalation)

H373 (blood system)

H400

H410

GHS07

GHS08

GHS09

Dgr

H317

H370 (lung)

(inhalation)

H373 (blood system)

H410

M = 1000 |

607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 |

Repr. 1B

STOT RE 1

Acute Tox. 4

H360F

H372

H302

GHS07

GHS08

Dgr

H360F

H372

H302

612-281-00-2 |

leucomalachite green;

N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline

204-961-9 | 129-73-7 |

Carc. 2

Muta. 2

H351

H341

GHS08

Wng

H351

H341

616-205-00-9 |

Metazachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0 | 67129-08-2 |

Skin Sens. 1B

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H351

H400

H410

GHS07

GHS08

GHS09

Wng

H317

H351

H410

M = 100

M = 100’